Novartis buys Endocyte for $2.1 billion
admin 18th October 2018 Uncategorised 0Novartis has signed a deal to acquire US biopharma Endocyte, securing itself access to novel radiopharmaceutical programmes “with significant sales potential”.
More: Novartis buys Endocyte for .1 billion
Source: News